research peptide retatrutide Triple Agonist (GLP-1/GIP/GCG) Retatrutide 10mg Research Peptide (GLP-1/GIP/Glucagon

With Novo Holdings $16.5 billion buyout of Catalent being reviewed by regulators, what work the contract drug manufacturer may or may not be performing for Eli Lilly remains a point of contention.

GLP-1 medications can be a powerful tool for weight loss and metabolic health, but they can also cause unwanted side effects from slowed digestion, such as constipation

The yerba mate market is set to grow from US$2.1 Bn in 2026 to US$3.0 Bn by 2033, driven by rising demand and a steady 5.2% CAGR

Compared to baseline, DIO mice assumed phylogenetically similar gut bacterial compositional changes following liraglutide and GUB09-145 treatment, characterized by discrete shifts in low-abundant species and related bacterial metabolic pathways

#ad Essentials when on a GLP-1

Always consult a qualified healthcare professional before considering any treatment related to weight management or metabolic health